E2F7, stabilized by VIRMA-mediated m6A and IGF2BP3, activates ITGA2, ITGA5, and NTRK1 transcriptionally in cooperation with RUNX1 and CBFB, thus facilitating NPC progression [74] (Table 1). The gene discussed is IGF2BP3; the disease is nasopharyngeal carcinoma.